The consensus among the NICE’s financial advisers is that Nice need to, generally, take as value powerful individuals interventions with an incremental cost-effectiveness ratio of significantly less than £20,000 for every QALY and that there ought to be increasingly robust good reasons for accepting as cost productive interventions with an incremental value-performance ratio of in excess of £30,000 for each QALY.